Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis.
Biddinger SB, Hernandez-Ono A, Rask-Madsen C, Haas JT, Alemán JO, Suzuki R, Scapa EF, Agarwal C, Carey MC, Stephanopoulos G, Cohen DE, King GL, Ginsberg HN, Kahn CR.
Biddinger SB, et al. Among authors: king gl.
Cell Metab. 2008 Feb;7(2):125-34. doi: 10.1016/j.cmet.2007.11.013.
Cell Metab. 2008.
PMID: 18249172
Free PMC article.